Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma

Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma J Cancer Res Clin Oncol (2017) 143:1649–1657 DOI 10.1007/s00432-017-2411-9 ORIGINAL ARTICLE – CANCER RESEARCH Development of a novel prognostic signature of long non‑coding RNAs in lung adenocarcinoma 1,2 1,2 3 4 1,2 Shanbo Zheng · Difan Zheng · Chuanpeng Dong · Jiahua Jiang · Juntao Xie · 1,2 1,2 Yihua Sun · Haiquan Chen Received: 21 December 2016 / Accepted: 29 March 2017 / Published online: 13 April 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract implications of prognostic lncRNAs were analyzed using Objectives Increasing evidence suggests that long non- the KEGG pathway functional enrichment analysis. coding RNAs (lncRNAs) may play a crucial role in many Results We identified eight lncRNAs which had prognos - biological processes in a variety of cancers and serve as the tic association with p value <0.01 in a TCGA lung adeno- basis for many clinical applications including prognostic carcinoma cohort of 478 patients. Then a novel prognos- biomarkers and potential therapeutic targets. The aim of tic signature with the eight lncRNAs was developed using this study is to develop a prognostic lncRNA signature with Cox regression model. Signature high-risk cases had worse RNA-seq data in lung adenocarcinomas. overall survival (OS, median 85.97 vs. 38.34 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Research and Clinical Oncology Springer Journals

Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma

Loading next page...
 
/lp/springer_journal/development-of-a-novel-prognostic-signature-of-long-non-coding-rnas-in-AOPGqcGLug
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Oncology; Cancer Research; Internal Medicine; Hematology
ISSN
0171-5216
eISSN
1432-1335
D.O.I.
10.1007/s00432-017-2411-9
Publisher site
See Article on Publisher Site

Abstract

J Cancer Res Clin Oncol (2017) 143:1649–1657 DOI 10.1007/s00432-017-2411-9 ORIGINAL ARTICLE – CANCER RESEARCH Development of a novel prognostic signature of long non‑coding RNAs in lung adenocarcinoma 1,2 1,2 3 4 1,2 Shanbo Zheng · Difan Zheng · Chuanpeng Dong · Jiahua Jiang · Juntao Xie · 1,2 1,2 Yihua Sun · Haiquan Chen Received: 21 December 2016 / Accepted: 29 March 2017 / Published online: 13 April 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract implications of prognostic lncRNAs were analyzed using Objectives Increasing evidence suggests that long non- the KEGG pathway functional enrichment analysis. coding RNAs (lncRNAs) may play a crucial role in many Results We identified eight lncRNAs which had prognos - biological processes in a variety of cancers and serve as the tic association with p value <0.01 in a TCGA lung adeno- basis for many clinical applications including prognostic carcinoma cohort of 478 patients. Then a novel prognos- biomarkers and potential therapeutic targets. The aim of tic signature with the eight lncRNAs was developed using this study is to develop a prognostic lncRNA signature with Cox regression model. Signature high-risk cases had worse RNA-seq data in lung adenocarcinomas. overall survival (OS, median 85.97 vs. 38.34

Journal

Journal of Cancer Research and Clinical OncologySpringer Journals

Published: Apr 13, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off